SCHEMBL14021995

SCHEMBL14021995

Cc1ccc(Oc2ccc3ncccc3c2)c(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
SCN9A Q15858 1/20 0.48
MET P08581 3/20 0.46
KDR P35968 3/20 0.46
SRC P12931 2/20 0.46
KIT P10721 1/20 0.46
FGFR2 P21802 1/20 0.46
AXL P30530 1/20 0.46
FLT3 P36888 1/20 0.46
MST1R Q04912 1/20 0.46
CYP3A4 P08684 1/20 0.43
PPARG P37231 1/20 0.43
DOT1L Q8TEK3 2/20 0.43
CHEK2 O96017 1/20 0.43
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
BRAF P15056 1/20 0.41
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9800640 0.84 MAPT (0.58) ALDH1A1SCN9AMETKDRSRC
SCHEMBL8736782 0.81 ALDH1A1 (0.66) ALDH1A1KDRAXLCYP3A4NPC1
SCHEMBL9800655 0.79 KMT2A (0.64) ALDH1A1SCN9ACYP3A4NPC1RAB9A
SCHEMBL17164822 0.77 NPC1 (0.61) ALDH1A1METKDRSRCKIT
SCHEMBL23063011 0.76 PPARG (0.56) ALDH1A1SCN9AMETKDRSRC
SCHEMBL130884 0.75 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9APDGFRB
SCHEMBL11420788 0.74 HTR2A (0.50) ALDH1A1CHEK2POLBRAB9AHTR2A
Ammonia Solution, Strong SCHEMBL27491586 0.74 ALDH1A1 (0.96) ALDH1A1NPC1POLBRAB9APDGFRB
SCHEMBL20172428 0.74 MPO (0.46) ALDH1A1PPARGCHEK2POLBRAB9A
SCHEMBL9800765 0.73 ALDH1A1 (0.68) ALDH1A1SCN9ACYP3A4PPARGPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269265-A1 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas MILLER SCOTT 2008-10-30 US disclosed
US-20080269265-A1 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas MILLER SCOTT 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269265-A1 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas BRAF, RAF1, MAP2K2 ALDH1A1 2032/4885SCN9A 4537/4885MET 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.